Dr. Leah Press, MD

Dr. Press practices at Minarets Medical Group, Inc. in Fresno, California.

Dr. Press' NPI, 1609985704, was assigned on August 30, 2006. Dr. Press graduated from Keck School of Medicine of USC in 1979. Dr. Press holds California license G42580.

Dr. Press' primary practice is Minarets Medical Group, Inc., at 1340 W Herndon Ave, Fresno, CA 93711 in Fresno County. The practice phone is (559) 438-1324.

Dr. Press' primary practice is Minarets Medical Group, Inc. in Fresno, California. The medical group on file is Minarets Medical Group. Dmand AI also links Dr. Press to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Press practices. Vendor and product names are available with a free account.

Dermatology is Dr. Press' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Press is board certified in dermatology by the American Board of Dermatology. Dr. Press is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Press treats.

CMS data shows 5,572 Medicare services from Dr. Press across 31 procedure codes in 2024, for 493 Medicare patients. Medicare paid $526,376 for them. Every service was in an office.

CMS counts 493 Medicare patients who saw Dr. Press in 2024. The largest group is 75 to 84, with 221 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Press' median patient age at 68, with 64% women.

In 2024, Dr. Press wrote 571 Medicare Part D claims for 160 patients. 81% of them were for generic drugs. CMS names the drug for 435 of them, across 20 drugs with 11 or more claims each, at $261,194 in total drug cost. In 2023, CMS named 401 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Press for performance year 2024, reported individually. Dr. Press accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Press as offering telehealth. CMS counts 1,302 procedures of removal of skin lesions by Dr. Press, more than 95% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Press in 2017. Dr. Press' most frequent co-authors are James L. Brazil, MD, Stephen W. Doggett, MD and Marketa Limova, MD.

CMS Open Payments shows 706 general payments to Dr. Press from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Sun Pharmaceutical Industries Inc. paid the most, $2,966.

Dmand AI lists 2 awards for Dr. Press.

Dr. Press graduated from Keck School of Medicine of USC in 1979. Dr. Press is a member of AAD and ASDS.

Dr. Press is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.